TWA
ATHE

TCI Wealth Advisors’s Alterity Therapeutics ATHE Stock Holding History

TCI Wealth Advisors’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2
Closed – – 1500
2018
Q1 		$0 Hold
2
– – ﹤0.01% 1350
2017
Q4 		$0 Hold
2
– – ﹤0.01% 1371
2017
Q3 		$0 Hold
2
– – ﹤0.01% 1320
2017
Q2 		$0 Hold
2
– – ﹤0.01% 1333
2017
Q1 		$0 Hold
2
– – ﹤0.01% 1282
2016
Q4 		$0 Sell
2
-8
-80% -$214 ﹤0.01% 1354
2016
Q3 		$0 Hold
10
– – ﹤0.01% 1355
2016
Q2 		$0 Hold
10
– – ﹤0.01% 1298
2016
Q1 		$0 Hold
10
– – ﹤0.01% 1325
2015
Q4 		$0 Hold
10
– – ﹤0.01% 1022
2015
Q3 		$1K Hold
10
– – ﹤0.01% 861
2015
Q2 		$1K Hold
10
– – ﹤0.01% 862
2015
Q1 		$1K Buy
+10
New +$798 ﹤0.01% 790

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

TCI Wealth Advisors's ATHE Position: Q2 2018 in Review

TCI Wealth Advisors sold out of Alterity Therapeutics (ATHE) in Q2 2018, closing a stake of 2 shares.

TCI Wealth Advisors first reported a position in ATHE in Q1 2015 and held it in 13 quarters. The position peaked at $1K in Q3 2015. 14 funds tracked by Wall St. Rank hold ATHE as of Q2 2018.

  • TCI Wealth Advisors reported no remaining Alterity Therapeutics position as of Q2 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 2 Alterity Therapeutics shares in Q2 2018.
  • TCI Wealth Advisors first reported a position in Alterity Therapeutics in Q1 2015 and held it in 13 quarters.
  • TCI Wealth Advisors's Alterity Therapeutics position peaked at $1K in Q3 2015.
  • 14 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2018.

Based on TCI Wealth Advisors's 13F filing for Q2 2018, filed 27 Jul 2018.